Another Legislative Proposal, Another Industry Divide
Rep. Morgan Griffith (R-VA) has put forward a hemp regulation alternative that takes a distinct approach from both the 2024 Farm Bill's enforcement framework and the competing proposals circulating in Congress — including the Hemp Safety Enforcement Act's state opt-out model and Rep. Barr's TTB-oversight proposal. Griffith's approach is drawing opposition from multiple directions, illustrating how difficult it has become to achieve consensus on federal hemp policy even among legislators who agree that the current situation is untenable.
For the B2B hemp ingredient supply chain, the proliferation of competing legislative proposals is creating a regulatory planning challenge that requires distinguishing between what is already law and what remains aspirational policy.
What Griffith Is Proposing
Griffith's hemp regulation framework centers on several key elements that differentiate it from other pending proposals:
Direct federal enforcement authority. Rather than delegating primary enforcement to states (as the Hemp Safety Enforcement Act would) or shifting oversight to TTB (as Barr's bill proposes), Griffith's approach would maintain federal agency authority as the primary regulatory mechanism — though with a more defined rulemaking mandate than FDA has historically been willing to adopt.
Product category distinctions. Griffith's framework would establish regulatory tiers based on product type — treating hemp food ingredients differently from hemp-derived smokables, beverages, and high-potency concentrates. Supporters argue this nuance is necessary to avoid regulatory overreach that harms legitimate agricultural and supplement industries.
Interim standards during rulemaking. To address the gap between the 2024 Farm Bill's November 12 compliance deadline and any final federal rulemaking, Griffith's approach would establish interim federal standards that give industry clear compliance targets while longer-term rules are developed.
Where the Opposition Is Coming From
The Griffith proposal is encountering resistance from both hemp industry stakeholders and anti-hemp advocates — for very different reasons.
From hemp advocates: Some in the hemp industry view Griffith's product category distinctions as creating unnecessary regulatory burdens for products they consider low-risk. Hemp beverage manufacturers, in particular, have objected to tiered treatment that might subject their products to more stringent oversight than competitors in the conventional beverage industry.
From anti-hemp advocates: Conversely, public health organizations and some state officials who want stricter hemp regulation view Griffith's interim standards as insufficiently protective — arguing that any framework that allows continued sale of hemp-derived intoxicants during a rulemaking period is irresponsible given documented youth access concerns.
From state sovereignty advocates: Legislators who support the Hemp Safety Enforcement Act's state opt-out model argue that Griffith's federal-primary approach undermines state authority to regulate hemp commerce within their own borders — a significant sticking point for senators from states like Missouri and Indiana that have passed their own restrictive hemp laws.
From the TTB camp: Supporters of Barr's Lawful Hemp Protection Act view Griffith's FDA-adjacent approach as perpetuating the problem — leaving hemp under the oversight of an agency that has demonstrated it lacks both the will and the resources to regulate the market effectively.
The Congressional Landscape
The existence of multiple competing hemp regulation proposals — Griffith's alternative, the Hemp Safety Enforcement Act, Barr's TTB bill, the Hemp Planting Predictability Act (which would delay the November 12 deadline to 2028), and others — reflects the fundamental disagreement in Congress about what federal hemp policy should accomplish.
Some members want to protect the hemp industry from what they view as overregulation. Others want to crack down on what they view as a loophole-exploiting intoxicant market. Some prioritize federal uniformity; others prioritize state authority. Some want FDA involvement; others want FDA removed entirely.
This fragmentation makes it unlikely that any single comprehensive hemp regulation bill passes before the November 12 deadline — which means the 2024 Farm Bill's existing standards are the operative law for compliance planning.
What the Proliferation of Proposals Means for Ingredient Buyers
For B2B hemp ingredient buyers and the formulators, manufacturers, and brands they supply, the number of competing legislative proposals creates a temptation to wait and see — to defer compliance investments until the regulatory landscape clarifies.
This is the wrong instinct. Here's why:
The November 12 deadline is law today. The 2024 Farm Bill has been signed. The compliance standards are established. No competing proposal changes that without being enacted — and none of the competing proposals have passed.
Legislative outcomes are uncertain; compliance requirements are not. Even if Congress eventually modifies the hemp regulatory framework, the path from proposal to enacted law takes time. Betting on legislative rescue before November 12 is a high-risk strategy.
Supplier vetting needs to happen now. Ingredient buyers who wait for regulatory clarity before evaluating their supply chains risk finding themselves without compliant sourcing options as the deadline approaches and non-compliant suppliers exit the market or face enforcement action.
The Practical Takeaway
Watch the Griffith proposal. Understand what it would mean for the long-term regulatory structure if it advances. But build your ingredient sourcing strategy around the compliance requirements that exist today:
- Total THC at or below 0.4mg per container
- Full-panel COA from ISO 17025-accredited, DEA-registered laboratories showing total THC calculation
- GMP-compliant manufacturing documentation
- Supplier track record and transparency on testing protocols
The congressional debate will continue well past November. Compliance cannot.
Low Gravity Hemp provides compliant hemp-derived ingredients to B2B buyers building for the federal regulatory environment. Contact our team to discuss your sourcing and compliance requirements.
